Related Experiment Video

Updated: Apr 5, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

[Challenge of gene-based personalized lung cancer medicine]

Yoshitaka Seki, Takashi Kohno

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |August 19, 2015
    PubMed

    Insights

    Identifying lung cancer driver genes improves targeted therapy. Comprehensive genomic analysis and liquid biopsies offer new noninvasive diagnostic and treatment strategies for lung cancer.

    Area of Science:

    • Oncology
    • Genetics
    • Molecular Biology

    Context:

    • Lung cancer is a leading cause of cancer death worldwide.
    • Several genes driving lung carcinogenesis have been identified.
    • Aberrations in these driver genes correlate with varied therapeutic responses.

    Purpose:

    • To review recent comprehensive genomic analyses in lung cancer.
    • To highlight the role of driver gene aberrations in treatment selection.
    • To discuss the potential of liquid biopsies for noninvasive molecular diagnosis.

    Summary:

    • Recent comprehensive analyses of DNA and RNA from lung tumor tissues are advancing lung cancer medicine.
    • Circulating cell-free tumor DNA (ctDNA) in plasma, or liquid biopsy, offers a promising noninvasive diagnostic approach.
    • Understanding driver gene aberrations is crucial for optimizing personalized lung cancer treatments.

    Impact:

    • Improved precision in lung cancer treatment selection based on genetic profiles.
    • Potential for earlier and less invasive cancer diagnosis through liquid biopsies.
    • Advancement of personalized medicine strategies for lung cancer patients.

    More Related Videos

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

    Published on: October 10, 2025

    532
    Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

    Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

    Published on: January 19, 2019

    18.5K

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    6.3K
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    1.8K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    1.8K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.1K
    Cancer02:18

    Cancer

    Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
    55.8K
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
    86